Zhong-Ping Chen Selected Research

Zhong-Ping Chen Research Topics

Disease

32	Neoplasms (Cancer) 09/2023 - 11/2004
30	Glioma (Gliomas) 01/2022 - 02/2002
13	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 08/2005
4	Brain Neoplasms (Brain Tumor) 12/2020 - 10/2009
4	Astrocytoma (Pilocytic Astrocytoma) 01/2015 - 11/2004
2	Breast Neoplasms (Breast Cancer) 10/2019 - 10/2018
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Ependymoma 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Transient Ischemic Attack 12/2020
1	Ischemic Stroke 12/2020
1	Lymphatic Metastasis 02/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Carcinogenesis 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Diffuse Intrinsic Pontine Glioma 01/2015
1	Meningioma (Meningiomas) 01/2012
1	Hypertension (High Blood Pressure) 09/2011

Drug/Important Bio-Agent (IBA)

11	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 12/2006
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2005
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2005
6	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
4	Protein Isoforms (Isoforms)IBA 07/2021 - 05/2016
3	InterferonsIBA 10/2022 - 11/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2021 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 05/2012 - 08/2008
2	elemeneIBA 10/2022 - 01/2017
2	URMC-099IBA 07/2021 - 01/2021
2	2- (1- (7- methyl- 2- morpholin- 4- yl- 4- oxo- 4H- pyrido(1,2- a)pyrimidin- 9- yl)ethylamino)benzoic acidIBA 07/2021 - 01/2021
2	Mitogen-Activated Protein Kinase Kinase Kinase 11IBA 07/2021 - 01/2021
2	ZyxinIBA 01/2021 - 05/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
2	AlbuminsIBA 11/2019 - 07/2017
2	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 10/2019 - 10/2018
2	Peptides (Polypeptides)IBA 10/2019 - 10/2018
2	Adenosine Triphosphatases (ATPase)IBA 10/2019 - 10/2018
2	nimotuzumabIBA 01/2019 - 01/2015
2	RNA (Ribonucleic Acid)IBA 11/2017 - 02/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 08/2005
2	Glial Fibrillary Acidic ProteinIBA 08/2017 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 08/2008
2	MethyltransferasesIBA 02/2014 - 12/2006
1	Dystroglycans (Dystroglycan)IBA 09/2023
1	Cancer VaccinesIBA 10/2022
1	Drug CombinationsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	lanthionineIBA 01/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 12/2020
1	Cytidine Triphosphate (CTP)IBA 12/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2020
1	Transferrin Receptors (Transferrin Receptor)IBA 06/2020
1	Estrogen ReceptorsIBA 02/2020
1	Thyroglobulin FDA Link 02/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2020
1	human ERBB2 proteinIBA 02/2020
1	Probucol (Lorelco)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	TenascinIBA 11/2019
1	TransferasesIBA 11/2019
1	UNBS 1450IBA 10/2018
1	myricetinIBA 01/2018
1	FlavonoidsIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Formaldehyde (Formol)FDA Link 11/2017
1	ParaffinIBA 11/2017
1	Histone Deacetylase InhibitorsIBA 09/2017
1	Beclin-1IBA 09/2017
1	Red Fluorescent ProteinIBA 08/2017
1	Serum AlbuminIBA 07/2017
1	Fibrinogen (Factor I)FDA Link 07/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	MTOR InhibitorsIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2015
1	artenimol (dihydroartemisinin)IBA 07/2015
1	Antimalarials (Antimalarial Agents)IBA 07/2015
1	artemisinin (artemisinine)IBA 07/2015
1	dipinacoline glutamateIBA 01/2015
1	Carmustine (FIVB)FDA Link 08/2014
1	PolymersIBA 08/2014
1	Complement System Proteins (Complement)IBA 02/2014
1	Alkylating AgentsIBA 02/2014
1	O-(6)-methylguanineIBA 02/2014
1	triptolideIBA 01/2014
1	CytokinesIBA 01/2013
1	Interleukin-7 (Interleukin 7)IBA 05/2012
1	Nerve Growth Factor (NGF)IBA 09/2011

Therapy/Procedure

11	Radiotherapy 01/2019 - 11/2004
9	Drug Therapy (Chemotherapy) 10/2022 - 11/2004
9	Therapeutics 01/2022 - 11/2004
2	Chemoradiotherapy 01/2022 - 10/2015
1	Craniotomy 03/2020
1	Aftercare (After-Treatment) 09/2017
1	Absorbable Implants 08/2014
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014